926 related articles for article (PubMed ID: 17204147)
21. The course of genetically determined chronic pancreatitis.
Keim V; Witt H; Bauer N; Bodeker H; Rosendahl J; Teich N; Mossner J
JOP; 2003 Jul; 4(4):146-54. PubMed ID: 12853682
[TBL] [Abstract][Full Text] [Related]
22. Cationic trypsinogen mutations and pancreatitis.
Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
Gastroenterol Clin North Am; 2004 Dec; 33(4):767-87. PubMed ID: 15528017
[TBL] [Abstract][Full Text] [Related]
23. Clinical and radiological outcome of patients suffering from chronic pancreatitis associated with gene mutations.
Frulloni L; Scattolini C; Graziani R; Cavestro GM; Pravadelli C; Amodio A; Manfredi R; Scarpa A; Vantini I
Pancreas; 2008 Nov; 37(4):371-6. PubMed ID: 18953248
[TBL] [Abstract][Full Text] [Related]
24. Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis.
Audrézet MP; Chen JM; Le Maréchal C; Ruszniewski P; Robaszkiewicz M; Raguénès O; Quéré I; Scotet V; Férec C
Eur J Hum Genet; 2002 Feb; 10(2):100-6. PubMed ID: 11938439
[TBL] [Abstract][Full Text] [Related]
25. Genetic factors in chronic pancreatitis; implications for diagnosis, management and prognosis.
Derikx MH; Drenth JP
Best Pract Res Clin Gastroenterol; 2010 Jun; 24(3):251-70. PubMed ID: 20510827
[TBL] [Abstract][Full Text] [Related]
26. [Chronic pancreatitis as a risk factor for pancreatic cancer].
Miyamoto T; Tashiro M; Otsuki M
Nihon Rinsho; 2006 Jan; 64 Suppl 1():22-6. PubMed ID: 16457214
[No Abstract] [Full Text] [Related]
27. Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis.
Teich N; Rosendahl J; Tóth M; Mössner J; Sahin-Tóth M
Hum Mutat; 2006 Aug; 27(8):721-30. PubMed ID: 16791840
[TBL] [Abstract][Full Text] [Related]
28. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
[TBL] [Abstract][Full Text] [Related]
29. Cationic trypsinogen mutations and pancreatitis.
Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
Clin Lab Med; 2005 Mar; 25(1):39-59. PubMed ID: 15749231
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic intraepithelial neoplasia is associated with chronic pancreatitis due to serine protease inhibitor kazal type 1 and cystic fibrosis transmembrane conductance regulator mutations.
Rebours V; Couvelard A; Sauvanet A; Hammel P; Ruszniewski P; Lévy P
Pancreas; 2010 Aug; 39(6):947-8. PubMed ID: 20664488
[No Abstract] [Full Text] [Related]
31. Is genetic analysis helpful for diagnosing chronic pancreatitis in its early stage?
Naruse S; Fujiki K; Ishiguro H
J Gastroenterol; 2007 Jan; 42 Suppl 17():60-5. PubMed ID: 17238030
[TBL] [Abstract][Full Text] [Related]
32. Genetic background of pancreatitis.
Hirota M; Ohmuraya M; Baba H
Postgrad Med J; 2006 Dec; 82(974):775-8. PubMed ID: 17148697
[TBL] [Abstract][Full Text] [Related]
33. Mutation analysis of PRSS1, SPINK1 and CFTR gene in patients with alcoholic and idiopathic chronic pancreatitis: A single center study.
Şişman G; Tuğcu M; Ayla K; Sebati Ö; Şentürk H
Turk J Gastroenterol; 2015 Mar; 26(2):176-80. PubMed ID: 25835118
[TBL] [Abstract][Full Text] [Related]
34. Analysis of CFTR, SPINK1, PRSS1 and AAT mutations in children with acute or chronic pancreatitis.
Sobczyńska-Tomaszewska A; Bak D; Oralewska B; Oracz G; Norek A; Czerska K; Mazurczak T; Teisseyre M; Socha J; Zagulski M; Bal J
J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):299-306. PubMed ID: 16954950
[TBL] [Abstract][Full Text] [Related]
35. Incidence, etiology and prognosis of first-time acute pancreatitis in young patients: a population-based cohort study.
Joergensen M; Brusgaard K; Crüger DG; Gerdes AM; Schaffalitzky de Muckadell OB
Pancreatology; 2010; 10(4):453-61. PubMed ID: 20720446
[TBL] [Abstract][Full Text] [Related]
36. Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis.
Chandak GR; Idris MM; Reddy DN; Mani KR; Bhaskar S; Rao GV; Singh L
Gut; 2004 May; 53(5):723-8. PubMed ID: 15082592
[TBL] [Abstract][Full Text] [Related]
37. The prevalence of cationic trypsinogen (PRSS1) and serine protease inhibitor, Kazal type 1 (SPINK1) gene mutations in Polish patients with alcoholic and idiopathic chronic pancreatitis.
Gasiorowska A; Talar-Wojnarowska R; Czupryniak L; Smolarz B; Romanowicz-Makowska H; Kulig A; Malecka-Panas E
Dig Dis Sci; 2011 Mar; 56(3):894-901. PubMed ID: 20676769
[TBL] [Abstract][Full Text] [Related]
38. Motion--genetic testing is useful in the diagnosis of nonhereditary pancreatic conditions: arguments for the motion.
Whitcomb DC
Can J Gastroenterol; 2003 Jan; 17(1):47-52. PubMed ID: 12560855
[TBL] [Abstract][Full Text] [Related]
39. Screening for human cationic trypsinogen (PRSS1) and trypsinogen inhibitor gene (SPINK1) mutations in a Finnish family with hereditary pancreatitis.
Räty S; Piironen A; Babu M; Pelli H; Sand J; Uotila S; Nordback I; Herzig KH
Scand J Gastroenterol; 2007 Aug; 42(8):1000-5. PubMed ID: 17613931
[TBL] [Abstract][Full Text] [Related]
40. Pathogenic cellular role of the p.L104P human cationic trypsinogen variant in chronic pancreatitis.
Balázs A; Hegyi P; Sahin-Tóth M
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G477-86. PubMed ID: 26822915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
